Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

436264

registered interest
date	08/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether he plan to respond to the Accelerated Access Review: Interim Report, published in October 2015; and if he will make a statement.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	19241
answer	answer is ministerial correction date of answer 15/12/2015 answer text <br /><p>The Interim Report of Sir Hugh Taylor’s Accelerated Access Review (AAR) is a deliberately high level document that indicates direction of travel; as such, government will be responding to the AAR’s conclusions when its final recommendations are published early in the spring of 2016.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/12/2015 16:30:10 answering member 4020 label Biography information for George Freeman
tabling member	3960 label Biography information for Henry Smith

436265

registered interest
date	08/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Leukaemia: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will ensure that the new Cancer Drugs Fund will increase patient access to medicines for acute myeloid leukaemia.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	19240
answer	answer is ministerial correction date of answer 15/12/2015 answer text <p>NHS England and the National Institute for Health and Care Excellence are currently consulting jointly on draft proposals on the future direction of the Cancer Drugs Fund.</p><br /><p>The consultation was published on 19 November 2015 and is open until 11 February 2016. It states that it is looking to put in place a solution that ensures patients have routine access to a greater range of cancer drugs, including earlier access to innovative drugs, while ensuring that cost-effectiveness is maintained. Further information is available at:</p><p>www.engage.england.nhs.uk/consultation/cdf-consultation</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/12/2015 16:22:51 answering member 4020 label Biography information for George Freeman
tabling member	3960 label Biography information for Henry Smith

436266

registered interest
date	08/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Lumacaftor/ivacaftor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when he expects Orkambi to be appraised by NICE.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	19234
answer	answer is ministerial correction date of answer 15/12/2015 answer text <p>The National Institute for Health and Care Excellence (NICE) is currently developing technology appraisal guidance on the use of Orkambi (lumacaftor in combination with ivacaftor) for the treatment of cystic fibrosis in people who are homozygous for the F508del mutation. NICE’s anticipated publication date for this guidance is July 2016. Further information is available at:</p><br /><p>www.nice.org.uk/guidance/indevelopment/gid-tag530</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/12/2015 16:20:22 answering member 4020 label Biography information for George Freeman
tabling member	4079 label Biography information for Julian Sturdy

436267

registered interest
date	08/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what representations he has received on reforming of NICE's procedure for appraisal of medicines.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	19235
answer	answer is ministerial correction date of answer 15/12/2015 answer text <p>We receive representations about the National Institute for Health and Care Excellence’s (NICE) technology appraisal programme from hon. Members, members of the public, clinicians and the pharmaceutical industry.</p><br /><p>NICE is the independent body that provides guidance on the prevention and treatment of ill health and the promotion of good health and social care and is responsible for its own processes and methodology.</p><br /><p>NICE regularly reviews these and its internationally renowned technology appraisal programme has evolved constantly to meet new challenges. NICE has demonstrated its ability to adapt to changes in the health and care environment, and we expect it will continue to evolve in the future, in particular through the recommendations of the Accelerated Access Review which NICE is centrally involved in.</p><br /><p>Further guidance on NICE’s processes of technology appraisal is available at:</p><br /><p>www.nice.org.uk/article/pmg19/chapter/Foreword</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/12/2015 16:28:02 answering member 4020 label Biography information for George Freeman
tabling member	4079 label Biography information for Julian Sturdy

436268

registered interest
date	08/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hydrotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will conduct a national review of hydrotherapy provision.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	19246
answer	answer is ministerial correction date of answer 10/12/2015 answer text <p>NHS England is responsible for commissioning specialised neurological services, which includes services for patients with neuromuscular disorders. NHS England has published a service specification for neurological care, which sets out what providers must have in place to offer evidence-based, safe and effective services. The specification can be found at the following link:</p><p>www.england.nhs.uk/wp-content/uploads/2013/06/d04-neurosci-spec-neuro.pdf</p><br /><p>Specialised neuromuscular care may include referral to local physiotherapy, hydrotherapy or rehabilitation if appropriate, however the commissioning of hydrotherapy services is a matter for local clinical commissioning groups. There are no plans to conduct a national review of hydrotherapy provision.</p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 18884 question first answered 10/12/2015 17:17:25 answering member 4020 label Biography information for George Freeman
tabling member	151 label Biography information for Tom Brake

435872

registered interest
date	07/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Muscular Dystrophy: Hydrotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will take steps to improve access for patients with muscular dystrophy to hydrotherapy services.
tabling member constituency	Chesham and Amersham
tabling member printed	Mrs Cheryl Gillan
uin	18884
answer	answer is ministerial correction date of answer 10/12/2015 answer text <p>NHS England is responsible for commissioning specialised neurological services, which includes services for patients with neuromuscular disorders. NHS England has published a service specification for neurological care, which sets out what providers must have in place to offer evidence-based, safe and effective services. The specification can be found at the following link:</p><p>www.england.nhs.uk/wp-content/uploads/2013/06/d04-neurosci-spec-neuro.pdf</p><br /><p>Specialised neuromuscular care may include referral to local physiotherapy, hydrotherapy or rehabilitation if appropriate, however the commissioning of hydrotherapy services is a matter for local clinical commissioning groups. There are no plans to conduct a national review of hydrotherapy provision.</p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 19246 question first answered 10/12/2015 17:17:24 answering member 4020 label Biography information for George Freeman
tabling member	18 label Biography information for Dame Cheryl Gillan

435878

registered interest
date	07/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Obesity: Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what account will be taken of NICE's clinical guidelines on levels of patient access in setting the budgets devolved by NHS England to clinical commissioning groups for obesity surgery from April 2016.
tabling member constituency	Totnes
tabling member printed	Dr Sarah Wollaston
uin	18841
answer	answer is ministerial correction date of answer 15/12/2015 answer text <p>NHS England would expect commissioners to take account of this guidance when commissioning services.</p><br /><p>Any transfer of budget from NHS England to devolved areas will be on the basis of existing contractual activity.</p><br /><p>Before the transfer of services, NHS England will complete a data capture exercise, working with providers through the specialised commissioning hubs, to collect the current activity level. This will provide the basis for the transfer of the budget. Governance sign off will then be agreed at NHS England Board level.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/12/2015 12:38:22 answering member 4020 label Biography information for George Freeman
tabling member	4073 label Biography information for Dr Sarah Wollaston

435879

registered interest
date	07/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Obesity: Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when NHS England's Clinical Reference Group for Severe and Complex Obesity will publish its proposed template for clinical commissioning groups on access to obesity surgery pathways and follow-up treatment.
tabling member constituency	Totnes
tabling member printed	Dr Sarah Wollaston
uin	18842
answer	answer is ministerial correction date of answer 15/12/2015 answer text <p>The template is in development and the draft will be shared in January 2016.</p><br /> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/12/2015 12:51:34 answering member 4020 label Biography information for George Freeman
tabling member	4073 label Biography information for Dr Sarah Wollaston

435881

registered interest
date	07/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Obesity: Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the potential effect on patient outcomes of the planned transfer of obesity surgery commissioning responsibilities to clinical commissioning groups from April 2016.
tabling member constituency	Totnes
tabling member printed	Dr Sarah Wollaston
uin	18864
answer	answer is ministerial correction date of answer 15/12/2015 answer text <p>We do not expect obesity outcomes to be affected, as the change will primarily be in regard to commissioning responsibilities. However, we believe the transfer should support better integration between Tier 3 and Tier 4 services (which include obesity services) which in turn should improve patient pathways.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/12/2015 12:56:11 answering member 4020 label Biography information for George Freeman
tabling member	4073 label Biography information for Dr Sarah Wollaston

435890

registered interest
date	07/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, for what reasons the New Medicine Service is not available to mental health patients.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	19041
answer	answer is ministerial correction date of answer 10/12/2015 answer text <p>The conditions/therapy areas selected for the New Medicine Service (NMS) are those where community pharmacies are best able to demonstrate the value of the service and could provide the greatest benefit to patients. The conditions/therapy areas are currently asthma and chronic obstructive pulmonary disease, type 2 diabetes, antiplatelet/anticoagulant therapy and hypertension.</p><br /><p>As the commissioners of National Health Service pharmaceutical services it is for NHS England to consider, in light of the best available evidence, whether to negotiate changes to the NMS including whether the NMS should be offered to mental health patients.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 10/12/2015 13:27:59 answering member 4020 label Biography information for George Freeman
tabling member	4036 label Biography information for Luciana Berger